2017 Press Releases
Aptinyx Raises $70 Million in Series B Financing to Advance Growing Pipeline through Clinical Studies in Neurologic Disorders (PDF Download)
December 18, 2017

Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer (PDF Download)
December 7, 2017


Arvinas Expands Strategic License Agreement with Genentech
November 15, 2017

Sanofi, Principia Agree To Develop Multiple Sclerosis Drug Candidate
November 9, 2017

Neuronetics Named 2017 Health Care Innovator by Philadelphia Business Journal
Recognized for company’s breakthrough non-drug depression treatment, NeuroStar® Advanced Therapy
October 9, 2017

Deciphera Pharmaceuticals Announces Pricing of Initial Public Offering
September 27, 2017

Alysha Fluno Joins Truveris as Chief Pharmacy Officer
September 15, 2017








Iterum Secures $65 Million in Series B Financing
May 19, 2017





TigerText Launches Role-based Scheduling Automation
February 16, 2017
